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Cell lysisLactobacillus plantarum C11 releases plantaricin A (PlnA), a cationic peptide pheromone that has a membrane-
permeabilizing, antimicrobial effect. We have previously shown that PlnA may also permeabilize eukaryotic
cells, with a potency that differs between cell types. It is generally assumed that cationic antimicrobial peptides
exert their effects through electrostatic attraction to negatively charged phospholipids in themembrane. The aim
of the present study was to investigate if removal of the negative charge linked to glycosylated proteins at the
cell surface reduces the permeabilizing potency of PlnA. The effects of PlnA were tested on clonal rat anterior
pituitary cells (GH4 cells) using patch clamp and microﬂuorometric techniques. In physiological extracellular
solution, GH4 cells are highly sensitive to PlnA, but the sensitivity was dramatically reduced in solutions that
partly neutralize the negative surface charge of the cells, in agreement with the notion that electrostatic interac-
tions are probably important for the PlnA effects. Trypsination of cells prior to PlnA exposure also rendered
the cells less sensitive to the peptide, suggesting that negative charges linked tomembrane proteins are involved
in the permeabilizing action. Finally, pre-exposure of cells to a mixture of enzymes that split carbohydrate resi-
dues from the backbone of glycosylated proteins also impeded the PlnA-induced membrane permeabilization.
We conclude that electrostatic attraction between PlnA and glycosylated membrane proteins is probably an es-
sential ﬁrst step before PlnA can interact with membrane phospholipids. Deviating glycosylation patterns may
contribute to the variation in PlnA sensitivity of different cell types, including cancerous cells and their normal
counterparts.
© 2012 Elsevier B.V. All rights reserved.1. Introduction
Nearly all organisms produce antimicrobial peptides, for review
see [1–4]. Some antimicrobial peptides from insects [5,6], amphibians
[7,8], and mammals [9,10] also kill a variety of tumor cells at concen-
trations not affecting normal eukaryotic cells, indicating a possible
therapeutic potential of such peptides (reviewed in [11]).
Antimicrobial peptides produced by bacteria, i.e., bacteriocins, are
usually more speciﬁc in their actions, and generally do not affect eu-
karyotic cells. However, we have recently shown that the antimicro-
bial peptide plantaricin A (PlnA), which is produced by Lactobacillus
plantarum C11, may permeabilize eukaryotic cells with a potency
that differs between cell types [12–14]. PlnA is primarily a peptide
pheromone that induces bacteriocin production in the strain fromBiosciences, University of Oslo,
47 844414, +47 92855894;
and),
and@imbv.uio.no (O. Sand),
rights reserved.which it is released [15,16]. However, the peptide also has membrane-
permeabilizing strain-speciﬁc antimicrobial activity [17,18].
Upon contact with the membrane, PlnA interacts with the mem-
brane lipids in a non-chiral manner, forming an α-helical structure
before binding to the receptor that induces the pheromone effect
[19]. The antimicrobial activity against sensitive bacterial strains is
probably linked to the initial membrane-interacting step.
In our ﬁrst study of membrane permeabilization of eukaryotic
cells induced by PlnA, we found that both the L- and D-form of PlnA
(10 μM) caused massive membrane permeabilization within seconds
in the cancerous rat pituitary GH4 cell line, while primary cell cultures
of rat anterior pituitary were insensitive to the peptide (1 mM) [13].
Unfortunately, later studies on other cell types showed that the effect
of PlnA is not restricted to cancerous cells [12,14]. However, Berge et al.
[20] have recently shown that high selectivity for cancer cells is not an
absolute requirement for utilizing lytic peptides in cancer treatment.
In these experiments, a lytic peptide derived from lactoferrin was
injected intratumorally. This treatment not only eradicated tumors by
local cell lysis, but more importantly also through induction of speciﬁc
immunity against all cells from the same clone as the lysed cells.
Similar results from treatment with oncolytic viruses, which activate a
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reported [21,22]. These results have instigated further investigation of
PlnA's mode of action.
Most antimicrobial peptides are cationic and amphiphilic or hy-
drophobic, and their antimicrobial effect is mainly due to membrane
permeabilization. It is generally assumed that electrostatic attraction
to negatively charged phospholipids facilitates the peptide's initial in-
teraction with the cell surface, whereas their amphiphilic or hydro-
phobic properties enables membrane insertion [18]. The molecular
mechanisms for the lytic effects are still not completely understood,
and suggested modes of action range from formation of distinct or
variable transmembrane pores to detergent-like effects on the mem-
brane [23–31]. PlnA's mode of action is probably in the latter category
[13].
In all cells, the various phospholipids are asymmetrically distributed
between the two membrane leaﬂets. Bacteria keep most of their nega-
tively charged phospholipids in the outer membrane leaﬂet, whereas
eukaryotic cells keep most of theirs, particularly phosphatidylserine,
in the inner leaﬂet by means of speciﬁc, energy-requiring transporters
(reviewed in [32]). Consequently, cationic antimicrobial peptides usual-
ly fail to permeabilize eukaryotic cell membranes [33–36]. However,
in cancerous and damaged cells, the density of negatively charged
phospholipids in the outer membrane leaﬂet is somewhat increased
[37–40], which is a favored explanation for why some antimicrobial
peptides permeabilize cancerous eukaryotic cells (reviewed in [11]).
In conﬂict with this hypothesis, we have previously shown that the
inner leaﬂet of the cell membrane of pituitary cells is resistant to PlnA
[13], indicating that negatively charged macromolecules associated
with the outermembrane leaﬂetmay be essential for thepermeabilizing
effect of PlnA. Glycosylated membrane proteins, which are important
components of the juxtamembrane environment, constitute a major
group of such macromolecules. These membrane proteins are structur-
ally divided into glycoproteins, with relatively short, branched or
unbranched glycan side chains, and proteoglycans, which are heavily
glycosylated with glycosaminoglycans (GAGs). These are negatively
charged, long, unbranched polysaccharides consisting of a single repeat-
ing disaccharide unit. The properties of this polymeric material
encoating all cells are highly diverse and vary between tissues and indi-
viduals. Interestingly, synthesis of proteoglycans is dramatically altered
during neoplastic transformation, and overexpression of various sub-
types has been shown in numerous malignancies [41–48]. Moreover,
marked structural alterations of GAG sidechains have also been recorded
[49–51].
We have previously suggested that electrostatic attraction to neg-
atively charged membrane-associated macromolecules may facilitate
membrane insertion of PlnA by ensuring a relatively high local con-
centration of the peptide close to the lipid bilayer [12–14]. The aim
of the present study was to examine if glycosylated membrane pro-
teins may be involved in such a mechanism, which might also explain
the variation in PlnA sensitivity among different cell types, and be-
tween neoplastic cells and their normal counterparts. We have inves-
tigated the effect of PlnA on GH4 cells, the clonal cell line previously
shown to be highly sensitive to PlnA [13], after various manipulations
of cell surface charge and composition of glycosylated membrane
proteins. Membrane permeabilization was monitored by measuring
membrane conductance and changes in the cytosolic Ca2+ concentra-
tion. The results suggest that electrostatic attraction between PlnA
and glycosylated membrane proteins is an essential ﬁrst step for
PlnA-induced membrane permeabilization and cell lysis.
2. Materials and methods
2.1. Synthesis and puriﬁcation of PlnA
Both the L- and D-enantiomeric forms of the 22-mer version of
PlnA were synthesized according to the amino acid sequence of thepeptide [15]: Tyr-Ser-Leu-Gln-Met-Gly-Ala-Thr-Ala-Ile-Lys-Gln-Val-
Lys-Lys-Leu-Phe-Lys-Lys-Trp-Gly-Trp. The natural L-form of PlnA-22
was purchased from GenScript (Piscataway, NJ, USA), at a purity of
more than 90 %. The D-enantiomer was synthesized locally, and puri-
ﬁed according to the method previously described [17]. The absor-
bance at 280 nm was measured, and the peptide concentration was
calculated using the molar extinction coefﬁcient at this wavelength.
The coefﬁcient at 280 nm is 12,660 M−1 cm−1 in 6.0 M guanidinium
hydrochloride, 0.02 M phosphate buffer, pH 6.5, as deduced from
PlnA's amino acid composition [16]. The net charge of the peptide is
approximately +5 at neutral pH. In a separate, ongoing study, the ef-
fects of both amino acid substitutions and peptide truncations on the
permeabilizing effect of PlnA is explored. Several of the substitutions
and truncations reduce or abolish the permeabilizing effects of PlnA.
For example, substitution of each one of the following amino acids
with proline virtually abolishes the membrane permeabilizing effect
of PlnA: valine-13, leucine-16 and phenylalanine-17 (residue #1 is
N-terminal tyrosine). Thus, the membrane permeabilizing ability of
PlnA is sequence-speciﬁc.
2.2. Culture of clonal rat anterior pituitary cells
The GH cell lines were originally derived from a rat pituitary
tumor [52]. These cells spontaneously synthesize and secrete prolac-
tin and/or growth hormone and are electrically excitable. In the pres-
ent study, we used the prolactin-secreting GH4C1 cell line. Cells were
grown as monolayer cultures in plastic tissue culture ﬂasks
containing Ham's F-10 medium supplemented with horse serum
(7.5 %), fetal calf serum (2.5%), penicillin (50 U mL−1), and strepto-
mycin (100 μg mL−1) at 37 °C in a humidiﬁed atmosphere of 5%
CO2 and 95% air. Cells were seeded in 35 mm plastic dishes
3–7 days prior to recording. In order to harvest cells from the culture
ﬂask, the normal growth medium was replaced with Ca2+-free
(EDTA) saline containing 200 mg/L trypsin (Lonza, Verviers, Bel-
gium). The trypsin solution was removed after 1 min, followed by
3 min incubation to allow detachment of the cells. The cells were
then suspended in growth medium, centrifuged for 3 min at 100 g,
and resuspended in growth medium before being seeded at a density
of 150,000 cells/cm2. For microﬂuorometric experiments, the cells
were seeded in similar dishes ﬁtted with a central glass bottom
14 mm in diameter. For Ca2+ imaging experiments, a circular border
of silicone was applied around the glass bottom, thus forming a per-
fusion chamber with a volume of approximately 0.6 mL. All experi-
ments were carried out at room temperature.
2.3. Experimental solutions
The physiologically adapted extracellular solution, hereafter called
“normal extracellular solution”, contained (mM): 150 NaCl, 5 KCl, 2.4
CaCl2, 1.3 MgCl2, 10 glucose, 10 HEPES/NaOH (pH 7.4). For the experi-
ments performed in isotonic solution with high extracellular Ca2+ con-
centration, CaCl2 and NaCl concentrations were altered to 24 mM and
118 mM, respectively. In these experiments, the solution with elevated
Ca2+ concentration was introduced 3–5 min prior to the recordings.
Patch electrodes were ﬁlled with the following solution (mM): 120
CH3SO3K, 20 KCl, 10 HEPES/NaOH, 20 sucrose (pH 7.2). Poly-D-lysine
hydrobromide (PDL) (Sigma, St. Louis, MO, USA) was dissolved in nor-
mal extracellular solution to a concentration of 5 mg/ml.
2.4. Enzyme treatment
Trypsin treatment of cells was performed with various concentra-
tions of trypsin, based on a solution of 25 g porcine trypsin/L in 0.9 %
NaCl (Sigma, MO, USA). Enzymes affecting glycosylated membrane
proteins were dissolved in a buffered solution that contained (mM):
150 NaCl, 5 KCl, 2.4 CaCl2, 1.3 MgCl2, 10 glucose, 5.5 CH3COONa, 10
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mixed together in 1.5 ml buffer: 200 chondroitinase ABC (cABC)
(Seikagu corp., Tokyo, Japan), 150 N-Glycosidase F (PNGase F)
(Roche, Mannheim, Germany), 0.25 heparinase I, II, II (Grampian
Enzymes, Orkney Islands, UK). Cells were incubated in the enzyme
mixture three hours prior to experiments.
2.5. Electrophysiology
Outside-out patch clamp recordings were used to directly monitor
the effects of PlnA on the membrane conductance, which mirrors the
membrane permeability. The patch electrodes weremade from borosil-
icate glass with ﬁlament and ﬁre-polished before use, and the electrode
resistance was 3–6 MΩ. The electrodes were connected to an EPC-7
patch-clamp ampliﬁer (Heka, Lambrecht/Pfaltz, Germany) controlled
by the software PClamp 9.2 (Axon Instruments, Union City, CA, USA).
The recorded signals were digitized at 10 kHz, ﬁltered at 3 kHz and
stored on a computer. Recordings were not adjusted for the electrode
junction potentials. Membrane currents ﬂowing from the extracellular
to the intracellular side were deﬁned as negative and displayed as
downward deﬂections in the current traces. Data analysis was
performed using PClamp 9.2 and Origin 7.0 (OriginLab, Northampton,
MA, USA). The excised patches were exposed to PlnA by pressure ejec-
tion (about 1 kPa) from a micropipette (inner tip diameter 1–2 μm)
placed about 40 μm from the excised patch. No artifacts were observed
when ejecting normal extracellular solution onto patches from this dis-
tance. Patches were pretreated for 1 min with poly-D-lysine (5 mg/L in
normal EC) or trypsin (25 g/L in 0.9% NaCl) by placing the patch within
the oriﬁce of the approximately 10 μm tip of a micropipette containing
the treatment solution. The micropipette was ﬁlled up to a level about
1 cm above that sustained by capillary action, thus securing a small
and even outward ﬂow of solution ﬂushing the patch. No artifacts
were observed during this pretreatment. Before exposure to PlnA, the
PDL- or trypsin-containing pipette was withdrawn from the bath.
2.6. Microﬂuorometry of fura-2-loaded cells
The cells were loaded with the ﬂuorescent Ca2+ indicator fura-2 by
exposure to 5 μm fura-2/AM (Invitrogen, Carlsbad, CA, USA) in extracel-
lular solution for 40 min at 37 °C, followed by washout of the fura-2
ester and further 30 min incubation at room temperature. For Ca2+ im-
aging, an Olympus IX71 invertedmicroscopewith objectives of high UV
light transmittance was used (Olympus, Tokyo, Japan). A Lambda 10–2
ﬁlterwheel (Sutter, CA, USA) switched the excitation light froma Lamb-
da LS Xenon Arc Lamp (Sutter, CA, USA) between 340 and 380 nm,
while the emitted ﬂuorescence was recorded at 510 nm. The exposure
times varied between 100 and 300 ms for 340 nm and between 50
and 150 ms for 380 nm, depending on the degree of cell loading with
fura-2. The ratio between emissions at these excitation wavelengths
(F340/F380) reﬂects the cytosolic Ca2+ concentration ([Ca2+]i ). Fluo-
rescence images were captured by a Hamamatsu ORCA ER camera
(Hamamatsu Photonics, Hamamatsu, Japan), and ratio images were
obtained at a frequency of 0.67 Hz. For controlling the hardware and
storing and analyzing the data, the software Imaging Workbench
5.2 (Indec Systems, CA, USA) was used. The digitized data were
background-subtracted, and the relative [Ca2+]i concentrations were
displayed by pseudo colors. In the present study, the relative increase
in [Ca2+]i is used as an indirect measure of reduced cell membrane in-
tegrity. Therefore, calibration in order to determine the absolute Ca2+
concentrations was not performed. Recording sessions lasted less than
5 min, and photobleaching or phototoxicity did not pose a problem
within this time span. The liquid volume in the perfusion chamber
was kept at 150–200 μl by applying continuous suction through a nar-
row tube appropriately positioned relative to the preferred surface
level. PlnA was applied by ﬂushing the chamber with 400–600 μl of
peptide-containing solution.The chamber perfusion used in the set-up for Ca2+ imaging re-
quires ﬁrm attachment of the cells to the bottom of the dish. Howev-
er, in the experiments testing the effects of PlnA on trypsinated cells,
the enzyme treatment partially detached the cells from the bottom of
the dish. In these experiments, we therefore recorded changes of
[Ca2+]i in single cells ﬁxed by a suction micropipette, and the ﬂuores-
cence from the selected cell was measured using a photomultiplier
tube. The dish with fura-2-loaded cells was then mounted on an
Olympus IMT-2 inverted microscope, forming the central part of the
Olympus OSP-3 system for dual excitation ﬂuorometry (Olympus,
Tokyo, Japan). The excitation light was switched at 200 Hz between
360 and 380 nm using a rotating mirror. The emitted ﬂuorescence
was recorded at 510 nm and the measurements were restricted to a
single cell by a pinhole diaphragm. Whereas the ratio F360/F380 re-
ﬂects [Ca2+]i, the emission at the isosbestic wavelength 360 nm is in-
dependent of [Ca2+]i, and thus monitors the cytosolic concentration
of the ﬂuorophore. Prior to experiments, the normal extracellular so-
lution was replaced with trypsin-containing solution obtained by di-
luting the 25 g trypsin L−1 stock solution with normal extracellular
solution to a ﬁnal trypsin concentration of 250 mg L−1. The cells
were incubated at room temperature for 3–5 min before the ﬁrst re-
cording. The cells were then either detached from the bottom or
only partially adherent. For each recording, a selected cell was there-
fore ﬁxed by a suction micropipette (suction about −5 kPa) with a
tip diameter of about 4 μm, and the cell was exposed to PlnA by pres-
sure ejection as described in Section 2.5.
3. Results
3.1. Neutralization of negative surface charges prevents membrane
permeabilization by PlnA
The assumption that electrostatic interactions are essential for the
membrane-permeabilizing effect of PlnA was tested by exposing cells
with reduced surface charge to the peptide. The negative surface
charge of cells can easily be partially neutralized by elevating the ex-
tracellular concentration of polyvalent cations, e.g. Ca2+, or adding
organic compounds with excess positive charge, e.g. poly-D-lysine,
to the extracellular solution. Therefore, in this series of experiments,
the permeabilizing effect of 10−4 M PlnA was studied on cells exposed
to either 24 mM Ca2+ or 5 mg/ml poly-D-lysine. At this concentration
of PlnA, the cell membrane of GH4 cells in normal extracellular solution
is rapidly disrupted [13].
Fig. 1 shows representative recordings from outside-out patches
voltage clamped at−50 mV during exposure to 10−4 M PlnA. The re-
cording in Fig. 1A was obtained in normal extracellular solution, and
PlnA was applied by pressure ejection directly onto the patch. Within
less than 5 s, the peptide induced a rapidly increasing inward current,
reﬂecting pronounced membrane permeabilization. However, in solu-
tions with 24 mM Ca2+ (Fig. 1B) or containing 5 mg/ml poly-D-lysine
(Fig. 1C), PlnA failed to permeabilize the membrane. The recordings
started about 5 min after replacement of the normal extracellular solu-
tion in the dish with the test solution, and the patches were exposed to
10−4 MPlnA for at least 3 min. In the 13 recordings obtained in solution
with elevated Ca2+ concentration and the 12 recordings acquired in so-
lution containing poly-D-lysine, the holding current was virtually stable
throughout the recording period in 11 and 9 of the recordings, respec-
tively. In order to conﬁrm the potency of PlnA, control recordings in nor-
mal extracellular solutionwere performed at regular intervals, and all of
the 18 control patches were readily permeabilized by 10−4 M PlnA.
3.2. Ca2+ imaging conﬁrms the dependence of negative surface charge
for the effect of PlnA
The results from the patch-clamp experiments were veriﬁed by
Ca2+ imaging, as shown in Fig. 2 for cells exposed to elevated Ca2+
0 nA
-0.5
-1.0
-1.5
5 s
PlnA
A
Control
PlnA
0 nA
-0.5
5 s
3 min
C
Poly-D-lysine
-2.0
PlnA
0 nA
-0.5
5 s
3 min
B
24 mM [Ca    ]2+
Fig. 1. Neutralization of negative surface charges inhibits membrane permeabilization by
PlnA. Representative recordings from outside-out patches voltage clamped at −50 mV
are displayed. Arrows indicate start of continuous pressure ejections of 10−4 M PlnA
onto the patches. (A) The peptide permeabilized the membrane in normal extracellular
solution, as shown by the induced membrane current. In extracellular solutions that neu-
tralize negative surface charges, i.e., with 10× increased Ca2+ concentration (24 mM)
(B) or 5 mg/ml poly-D-lysine (C), 10−4 M PlnA failed to permeabilize the membrane.
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The ratio images of fura-2-loaded cells in these ﬁgures display relative
[Ca2+]i by pseudo colors, where dark blue represents resting levels
and dark red indicates saturating levels of [Ca2+]i. Figs. 2A and 3A
show cells from two different seedings in normal extracellular solution.
The frames are separated by 5 s, and the ﬁrst image in each panel was
taken immediately before the cell chamber was ﬂushed with solution
containing 10−4 M PlnA. Already in the second image of each panel,
i.e., less than 5 s after exposure to PlnA, some of the cells displayed
an obvious color shift showing a rapid increase of [Ca2+]i. Within
20–25 s, nearly all cells in the ﬁeld of view reached saturating
levels of [Ca2+]i, suggesting increased Ca2+ inﬂux due to membrane
permeabilization.
Fig. 2B presents a similar experiment on cells in solution with 10×
increased Ca2+ concentration (24 mM). The time interval between
the merged frames is 5 s, while the last, separated frame was taken
3 min after start of PlnA exposure. Whereas cells were clearly perme-
abilized by 10−4 M PlnA in normal extracellular solution in less than
20–25 s (Fig. 2A), the [Ca2+]i of cells in the solution with elevated
Ca2+ concentration was seemingly rather stable, even after 3 min
exposure to 10−4 M PlnA (Fig. 2B). This series of experiments
comprised 5 control dishes with normal extracellular solution and 6
dishes containing solution with 24 mM Ca2+ concentration. Control
recordings were performed at regular intervals during the experi-
ments, in order to test the potency of PlnA on cells from thisparticular seeding. In all the control dishes with normal extracellular
solution, the cells displayed pronounced elevation of [Ca2+]i within
less than 30 s in response to 10−4 M PlnA. In the control experi-
ments, the F340/F380 ratio of the observed cells increased by a factor
of 4.8±1.1 (S.D., n=100) after 30 s exposure to 10−4 M PlnA.
However, in the solution with elevated Ca2+ concentration, the
F340/F380 ratio of the recorded cells increased by a factor of only
1.2±0.2 (n=110) after 3 min exposure to 10−4 M PlnA. This differ-
ence in ratio increase between the two experimental situations is
highly signiﬁcant (Student t-test, pb0.0001).
In a corresponding series of experiments, the effect of 10−4 M
PlnA was also studied on cells in extracellular solution containing
5 mg/ml poly-D-lysine (Fig. 3B), and the result was essentially the
same as that described for cells in solution with 24 mM Ca2+. In
these experiments, 4 control dishes with normal extracellular solu-
tion and 4 dishes containing solution with 5 mg/ml poly-D-lysine
were included. In all the dishes with normal extracellular solution,
10−4 M PlnA induced pronounced elevation of [Ca2+]i within less
than 30 s in virtually all the cells. The F340/F380 ratio of the control
cells increased by a factor of 4.3±1.3 (n=46) after 30 s exposure
to 10−4 M PlnA. In contrast, the F340/F380 ratio of cells in solution
containing poly-D-lysine increased to only 1.2±0.1 (n=33) after
3 min exposure to 10−4 M PlnA, and this value is signiﬁcantly less
than the ratio increase in the control cells (pb0.0001).
The conclusion from both the patch clamp and the Ca2+ imaging
experiments is that electrostatic interaction between the cationic
PlnA molecule and the negative surface charge of the cell is probably
an essential step in the membrane-permeabilizing action of PlnA.
3.3. Trypsin-treated cells are resistant to PlnA
Although the experiments described in the previous sections dem-
onstrate that negative surface charges are involved in the membrane-
permeabilizing effect of PlnA, they do not reveal the speciﬁc cell surface
components crucial for the peptide-membrane interactions. A major
part of the total negative surface charge of a cell is linked to various
membrane-associated proteins. To investigate their possible role in
the membrane permeabilization caused by PlnA, the endoprotease
trypsin was used to cleave extracellular parts of membrane anchored
proteins protruding from the cell surface.
The effect of 10−4 M PlnA on trypsin-treated cells was initially
studied by patch clamp experiments similar to those described in
Section 3.1, and Fig. 4 shows representative recordings from
outside-out patches voltage clamped at −50 mV during exposure to
10−4 M PlnA. Immediately after excision, outside-out patches were
locally exposed to 25 g/L trypsin for 1 min, and the delivery pipette
was removed from the dish between treatments (see Section 2.5).
In contrast to the rapid development of a large inward current in
untreated cells exposed to 10−4 M PlnA (Fig. 1A), pressure ejection
of 10−4 M PlnA solved in trypsin-free solution directly onto
trypsin-treated patches for more than 2 min induced no inward cur-
rent (Fig. 4B). A total number of 10 trypsin-treated patches were ex-
posed to PlnA in this manner, and a pronounced inward current
subsequent to the peptide application was observed in only 1 of
these patches. At regular intervals during this series of experiments,
control recordings were performed from 7 untreated patches, all of
which responded to 10−4 M PlnA with a large conductance increase.
Even though the trypsin-treated patches were exposed to PlnA in
normal, enzyme-free solution, trypsin molecules might still remain
attached to the patch surface after the local pretreatment with the en-
zyme. In order to test if the lack of PlnA-induced conductance in-
crease was due to degradation of PlnA by such reminiscent trypsin,
similar experiments were performed using the D-enantiomeric form
of PlnA. The effect of trypsin on both L- and D-PlnA was tested
using mass spectrometry to identify intact PlnA molecules and possi-
ble degradation products. Incubation of a solution with 10−3 M PlnA
Fig. 2. Ca2+ imaging conﬁrming that elevated extracellular Ca2+ concentration inhibits membrane permeabilization by PlnA. The images displaying the cytosolic Ca2+-concentration
([Ca2+]i) are based on the ﬂuorophore fura-2. Dark blue represents resting level and dark red indicates saturating levels of [Ca2+]i. The time interval between merged frames is
5 s and the ﬁrst image in each series was taken just before start of PlnA exposure. The last, separated frame in B was taken 3 min after start of PlnA exposure. (A) Cells exposed to
10−4 M PlnA show a rapid increase in [Ca2+]i, indicating enhanced Ca2+ inﬂux due to membrane permeabilization. (B) In extracellular solution with 10× increased Ca2+ concentration
(24 mM), 10−4 M PlnA failed to permeabilize the cell membranes.
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dation (>95 %) of the L-form after 20 min, whereas the D-form was
completely resistant to degradation. We have previously shown that
D-PlnA is as effective as L-PlnA in permeabilizing GH4 cells [13], and
this was veriﬁed in the present study (Fig. 4A). A total number of 9
outside-out patches from untreated cells in normal extracellularFig. 3. Ca2+ imaging conﬁrming that extracellular poly-D-lysine inhibits membrane permeab
based on the ﬂuorophore fura-2. Dark blue represents resting level and dark red indicates sa
image in each series was taken just before start of PlnA exposure. The last, separated frame in
a rapid increase in [Ca2+]i, indicating enhanced Ca2+ inﬂux due to membrane permeabilizat
cell membranes.solution were exposed to 10−4 M D-PlnA, and all of these patches
responded in a manner similar to the one presented in Fig. 4A.
The recording in Fig. 4C is from a trypsin-treated patch exposed to
D-PlnA. The holding current was virtually stable during more than
3 min continuous pressure ejection of D-PlnA onto the patch, and a
similar lack of noticeable conductance increase was observed in 6 ofilization by PlnA. The images displaying the cytosolic Ca2+-concentration ([Ca2+]i) are
turating levels of [Ca2+]i. The time interval between merged frames is 5 s and the ﬁrst
B was taken 3 min after start of PlnA exposure. (A) Cells exposed to 10−4 M PlnA show
ion. (B) In solution with 5 mg/ml poly-D-lysine, 10−4 M PlnA failed to permeabilize the
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Fig. 4. Trypsin-treated membranes have reduced sensitivity to PlnA. Representative re-
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permeabilize the membrane, showing that the diminished permeabilizing effect of PlnA
was not due to cleavage of the peptide by membrane-associated trypsin remaining from
the pretreatment.
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Fig. 5.Microﬂuorometric recordings verifying that trypsin-treated cells have reduced sen-
sitivity to PlnA. The recordings are from single, fura-2-loaded cells exposed to PlnA. The
ratio between emissions at the excitation wavelengths 360 and 380 nm (F360/380) re-
ﬂects the cytosolic Ca2+ concentration ([Ca2+]i), whereas absolute emission at the
isosbestic excitation wavelength 360 nm (F360) reﬂects [fura-2]i. Arrows indicate start
of continuous pressure ejection of 10−4 M PlnA onto the cell. (A) In normal extracellular
solution, D-PlnA elevated [Ca2+]i to saturating levels followed by delayed loss of
ﬂuorophore, indicating massive membrane permeabilization. (B) Comparable recording
showing lack of [Ca2+]i elevation and no diffusional loss of ﬂuorophore from a cell in so-
lution containing 250 mg/L trypsin. Because trypsin detaches adherent cells from the bot-
tom of the dish, the cell was ﬁxed by a micro suction-pipette during ﬂushing with PlnA
(solved in trypsin- free solution). The presented cell was exposed to D-PlnA, but lack of
[Ca2+]i elevation in trypsin-containing solution was observed with both L-PlnA and
D-PlnA. (C) Recording in Ca2+-free solution showing lack of [Ca2+]i elevation in response
to PlnA application. The F360 trace reveals profound loss of ﬂuorophore from the cytosol
after a short delay, verifying that the cell was permeabilized by PlnA also in this solution.
The increasing noise level of the ratio traces in A and C is due to the reduced signal to noise
ratio when ﬂuorophore is lost from the cell.
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increased resistance to PlnA after trypsin treatment of the patch is
due to degradation of membrane associated proteins, and not to
breakdown of PlnA.
It is unlikely that the lack of PlnA effects on trypsin-treated
patches is due to destruction of speciﬁc membrane receptors involved
in the action of PlnA, due to the similar effects of L-and D-PlnA in nor-
mal solution. A receptor-mediated mechanism could hardly be acti-
vated equally by these two enantiomeric forms of PlnA.
3.4. Microﬂuorometric recordings verify that trypsin-treated cells are
resistant to PlnA
The conclusion based on the experiments described in the previ-
ous section was supported by microﬂuorometric measurements of
relative [Ca2+]i in trypsin-treated cells exposed to 10−4 M PlnA. In
these experiments, the solution in the dish contained 250 mg tryp-
sin/L, which caused the cells to partially detach from the bottom of
the dish. Therefore, ﬂuorescence changes reﬂecting altered [Ca2+]i
were measured in selected, single cells ﬁxed by a suction micropi-
pette. PlnA in trypsin-free solution was then applied to the selected
cell by pressure ejection through a micropipette aimed at the cell,
rather than ﬂushing the cell chamber with PlnA-containing solution.
In these experiments, the emission from the selected cell was mea-
sured using a photomultiplier tube, as described in Section 2.6. Thetrypsin treatment used in this series of experiments is similar to the
procedure employed to detach cells prior to reseeding during the
cell culture. Thus, the cells stay viable and are able to undergo mitosis
after incubation in the trypsin-containing solution.
Fig. 5A shows a control recording of the F360/F380 ratio, representing
[Ca2+]i, from an untreated cell exposed to 10−4 MD-PlnA in normal ex-
tracellular solution. A recording of the relative emission intensity at the
isosbestic excitation wavelength of 360 nm (F360), representing the cy-
tosolic concentration of fura-2 ([fura-2]i), is also included in the ﬁgure.
Exposure to 10−4 M PlnA rapidly increased [Ca2+]i to saturating levels,
reﬂecting enhanced Ca2+ inﬂux due tomembrane permeabilization. Fol-
lowing the rapid increase in [Ca2+]i, a delayed and almost total loss of the
large ﬂuorophore fura-2 is evident from the trace representing [fura-2]i,
indicating severe disruption of the cell membrane. A total number of 25
similar control recordings were performed at regular intervals during
this series of experiments, which also included 28 recordings from
trypsin-treated cells. Both L-PlnA (n=35) and D-PlnA (n=18) were
used in these experiments, and all the control recordings were qualita-
tively similar to that depicted in Fig. 5A. The two-step increase of
[Ca2+]i displayed in this ﬁgure may indicate a beginning recovery from
the PlnA effect, before the cell was overwhelmed by the disruptive
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255S.L. Sand et al. / Biochimica et Biophysica Acta 1828 (2013) 249–259peptide action. However, a rapid and continuous elevation of [Ca2+]i to
the peak value was a more common response.
Fig. 5B shows representative recordings of both the F360/F380
ratio and F360 from a cell incubated in trypsin. PlnA solved in
trypsin-free solution was ejected directly onto the recorded cell,
which was thus superfused with trypsin-free solution during the re-
cording. Continuous pressure ejection of 10−4 M D-PlnA onto the
cell for more than 3 min had no effect on [Ca2+]i, and the modest de-
cline of F360 was probably due to photo-bleaching rather than to dif-
fusional loss of fura-2. In merely 4 of the 28 experiments with cells
incubated in trypsin did ejection of either L-PlnA (n=18) or D-PlnA
(n=10) induce elevation of [Ca2+]i, thus excluding the possibility
that lack of PlnA effects was due to instant peptide degradation by
remaining trypsin adhered to the cell surface when PlnA solved in
trypsin-free solution was pressure ejected onto the cells.
In order to test the possibility that the PlnA-induced elevation of
[Ca2+]i in normal solution might be due to release from intracellular
stores, rather than Ca2+ inﬂux through a disrupted cellmembrane, sim-
ilar experiments were also performed in Ca2+-free solution containing
0.5 mM EGTA. Fig. 5C shows a recording of the F360/F380 ratio and
F360 from one of the 6 cells tested in this solution. In all the cells,
PlnA failed to elevate [Ca2+]i, although themembrane-disruptive action
of the peptide was evident from a similar diffusional loss of fura-2 as
seen in normal solution. Therefore, the elevation of [Ca2+]i induced by
PlnA in normal solution is due to inﬂux of extracellular Ca2+.
Based on the data from both the patch clamp and the micro-
ﬂuorometric recordings, it is reasonable to conclude that membrane-
associated proteins are important for the membrane-permeabilizing
effect of PlnA.5 s
-0.5
-1.0
-1.5
-2.0
Fig. 6. Carbohydrate removal from glycosylated membrane proteins inhibits mem-
brane permeabilization by PlnA. Representative recordings from outside-out patches
voltage clamped at −50 mV are displayed. Arrows indicate start of continuous pres-
sure ejections of 10−4 M PlnA onto the patches. (A) Control recording showing the
permeabilizing effect of PlnA. (B) In patches from cells pre-exposed to a mixture of en-
zymes that split carbohydrate residues from the backbone of proteins, PlnA failed to
permeabilize the membrane. (C) After a period of about 1.5 h in normal extracellular
solution, the enzyme-treated cells regained their sensitivity to PlnA.3.5. Removal of carbohydrate residues from glycosylated membrane
proteins prevents membrane permeabilization by PlnA
The reducedmembrane sensitivity to PlnA induced by trypsin treat-
ment does not reveal which parts of themembrane-associated proteins
that are involved in the PlnA-membrane interactions. The experiments
described in Sections 3.1–2 demonstrate that negative surface charge
of the cell membrane is probably important for the membrane-
permeabilizing effect of PlnA. Several types of carbohydrate residues
linked to the protein backbone of membrane-associated glycoproteins
and proteoglycans carry negative charges. For example, the glycosami-
noglycans linked to the protein core of proteoglycans are negatively
charged because of the prevalence of sulphate groups. In an attempt
to identify molecular groups involved in mediating the membrane-
permeabilizing effect of PlnA, cells were exposed to a mixture of en-
zymes that cleave carbohydrate residues from protein backbones, i.e.,
PNGase F, chondroitinase ABC, and heparinase I, II, III.
The effect of 10−4 M PlnA on cells treated with the enzyme mixture
speciﬁed in Section 2.4 for 2–3 hwas initially studied by patch clamp ex-
periments similar to those described in Section 3.1. Cells incubated with
the enzymemixture according to the described protocol stayed viable in
culture, and kept their ability of mitotic cell division. Contrary to the in-
ward current rapidly induced by 10−4 M PlnA in outside-out patches
from untreated cells (Fig. 6A), exposure to 10−4 M PlnA for more than
2 min induced no detectable inward current in the outside-out patch
from the enzyme-treated cell presented in Fig. 6B. This recording started
about 5 min after replacement of the enzyme solution in the dish with
normal extracellular solution, and a total number of 7 patches from
cells treated with the enzyme mixture were exposed to 10−4 M PlnA
within one hour after wash-out of the enzyme-containing solution. A
prominent inward current subsequent to PlnA exposure was observed
in only 1 of these patches. At regular intervals during this series of exper-
iments, 4 control recordings were performed from sham-treated cells of
the same seeding. The same procedures were then followed regarding
solution changes, incubation period, and timing of the recordings, butonly normal extracellular solution was applied. In all of the control re-
cordings, 10−4 M PlnA induced a pronounced inward current (Fig. 6A).
In live cells, there is a constant turnover of membrane associated
proteins and their carbohydrate side chains. Thus, when the enzyme-
containing solution was replaced with normal extracellular solution, it
was to be expected that normalmembrane compositionwould gradual-
ly be reestablished. Indeed, Fig. 6C shows a representative recording
from a patch excised from a cell 1.5 h after removal of the solution
containing the enzyme mixture, and it is evident that the cell had
regained its sensitivity to PlnAduring this period. Among the 10patches
excised between 1 h and 2 h after exchange of the test solution with
normal extracellular solution, 10−4 M L-PlnA induced a pronounced
inward current in 6 patches. All the 8 patches excised more than 2 h
256 S.L. Sand et al. / Biochimica et Biophysica Acta 1828 (2013) 249–259after termination of the enzyme treatment were rapidly permeabilized
by 10−4 M L-PlnA.3.6. Ca2+ imaging conﬁrms that the effect of PlnA is dependent on
glycosylated proteins
The results from the patch-clamp experiments presented above
were veriﬁed by Ca2+ imaging experiments similar to those described
in Section 3.2. Fig. 7A depicts a control recording from sham-treated
cells, and shows that all cells in the ﬁeld of view displayed an apparent
color shift representing a rapid increase of [Ca2+]i less than 5 s after
exposure to 10−4 M PlnA. After 20–25 s, most cells had reached satu-
rating levels of [Ca2+]i. Fig. 7B presents a recording from cells of the
same seeding incubated with enzyme mixture for 2 h, and 10 min
after replacement of the enzyme-containing solution with normal ex-
tracellular solution. As opposed to the obviously increased [Ca2+]i in
the control cells (Fig. 7A), the [Ca2+]i of cells pre-treated with the en-
zyme mixture was seemingly quite stable, even after 3 min exposure
to 10−4 M PlnA.
This series of experiments comprised 4 dishes with cells pre-treated
with the enzyme mixture less than 50 min prior to the recording. The
control recordings from sham-treated disheswere performed at regular
intervals in order to test the potency of 10−4 M PlnA on cells from
this particular seeding. In all the 3 control dishes, the cells displayed
pronounced elevation of [Ca2+]i within less than 30 s in response to
10−4 M PlnA. In the control experiments, the F340/F380 ratio of the ob-
served cells increased by a factor of 4.4±1.2 (n=50) after 30 s expo-
sure to 10−4 M PlnA. However, when pretreated with the enzyme
mixture, the F340/F380 ratio of the recorded cells increased by a factor
of only 1.1±1.1 (n=80) after 3 min exposure to 10−4 M PlnA. This
difference in ratio increase between the sham-treated and enzyme-
treated cells is highly signiﬁcant (pb0.0001). Probably due to strainFig. 7. Ca2+ imaging conﬁrming the dependence of glycosylated membrane proteins for th
based on the ﬂuorophore fura-2. Dark blue represents resting level and dark red indicates
image in each series was taken just before start of PlnA exposure. The last, separated fram
[Ca2+]i induced by 10−4 M PlnA, indicating membrane permeabilization. (B) In cells pre-
of proteins, PlnA failed to permeabilize the membrane.on the cells exerted by the combination of the fura-2 loading procedure
and the enzyme treatment for more than 2 h, the cells started to detach
from the bottom of the dish before 1 h after wash-out of the enzyme
mixture. Therefore, we were not able to verify by Ca2+ imaging that
the enzyme-treated cells started to regain their sensitivity to PlnA
after about 1 h in normal extracellular solution.4. Discussion
It is generally assumed that electrostatic attraction to negatively
charged phospholipids initiates permeabilization of cell membranes
by cationic and amphiphilic antimicrobial peptides, but other factors
may also be essential in this process. Negatively charged phospho-
lipids are more abundant in the inner leaﬂet than in the outer leaﬂet
of eukaryotic cell membranes, but we have previously shown that the
membrane is permeabilized less readily by PlnA if the inner leaﬂet is
exposed to the peptide [12,13]. Therefore, we suggested that anionic
phospholipids alone cannot explain the peptide–membrane interac-
tion [13], and that negatively charged membrane proteins may be es-
sential for the lytic effect of PlnA.
In the present study, we showed that the permeabilizing potency
of PlnA diminished in extracellular solutions that partially neutralize
negative cell surface charge. Although these results are compatible
with the notion that electrostatic attraction is involved in the perme-
abilization mechanism, they are not deﬁnite proof of such a mecha-
nism. For example, Ca2+ and polyvalent cationic poly-D-lysine may
also have a stabilizing effect on the membrane by bridging anionic
groups of various membrane constituents. The involvement of mem-
brane proteins in PlnA's action on the membrane was demonstrated
by the impeded lytic potency of the peptide after enzymatic removal
of extracellular regions of membrane proteins or their carbohydrate
residues. However, the membrane permeabilization of eukaryotice effect of PlnA. The images displaying the cytosolic Ca2+-concentration ([Ca2+]i) are
saturating levels of [Ca2+]i. Time interval between merged frames is 5 s and the ﬁrst
e in B was taken 3 min after start of PlnA exposure. (A) Control recording of elevated
exposed to a mixture of enzymes that split carbohydrate residues from the backbone
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essarily be facilitated by negatively charged membrane proteins. If
this attraction is sufﬁciently strong to prevent dissociation of the pep-
tide and its subsequent insertion into the lipid bilayer, the membrane
proteins may instead function as a screen that protects the cell
against the lytic effect of the peptide. Such a screening mechanism
has recently been described by Fadnes et al. [53] for the the peptides
bovine lactoferricin and a designer peptide, but the same group has
later shown that surface-bound heparan sulfate may enhance the
lytic effect of small peptides [54]. Furthermore, eukaryotic cell mem-
brane penetration by a 22-mere peptide derived from human
lactoferrin is dependent on initial binding to heparan sulfate [55].
Thus, the consequences of the interference between glycosylated
membrane proteins and lytic peptides seem to depend on the proper-
ties of the peptide, and range from protection against lysis to facilita-
tion of the membrane permeabilizing effect.
Theﬁgures presented in Section 3may give the impression that neu-
tralizing negative cell surface charge or cleaving off extracellular parts
of membrane proteins or their carbohydrate residues render the cells
completely resistant to PlnA. However, this may of course not be the
case. In a previous ﬂow-cytometric study of the effect of PlnA on the in-
tegrity of both normal and transformed lymphocytes, we showed that
the dose–response relationship for the membrane-disrupting effect of
PlnA is very steep,with a ratio of about 5 between the lowest concentra-
tion permeabilizing virtually all the cells and a concentration that has
no detectable effect [13]. Therefore, PlnA at a concentration inducing a
full-ﬂedged response in control cellsmay be completely ineffective sub-
sequent to cell treatments thatmerely reduce the sensitivity of the cells
to PlnA. A possible right-shift of the dose–response relationship for
the effect of PlnA might have been revealed by testing higher concen-
trations of the peptide. However, the main objective of the present
study was to demonstrate possible involvement of negatively charged
membrane proteins in the PlnA-induced membrane permeabilization,
and not to establish post-treatment dose–response curves for the PlnA
effect.
In order to test if glycosylated membrane proteins facilitate PlnA-
induced membrane permeabilization, we employed a mixture of the
enzymes chondroitinase ABC, heparinase I, II, III, and N-Glycosidase F
to cleave off various carbohydrate residues from membrane proteins.
The chondroitinases cleave various chondroitins, the most prevalent
of all the glycosaminoglycans, while the heparinases are active toward
both heparan sulfate and heparin, which has the highest negative
charge density of any known biologicalmolecule. N-Glycosidase F catal-
yses hydrolysis of numerous N-linked glycans. Obviously, treatment
with this enzyme mixture is not very speciﬁc, but rids the membrane-
associated proteins of the most signiﬁcant negatively charged carbohy-
drate residues. It would of course be interesting to scrutinize the
relative importance of the various carbohydrate groups, which could
be achieved by applying the enzymes individually and in different com-
binations. The involvement of the various carbohydrate residues are
probably not all-or-none, and the use of speciﬁc enzyme treatment to
resolve the relative importance of the different groups is likely to be
rather extensive and the results difﬁcult to interpret. Such experiments
are beyond the main objective of the present project, but should be in-
cluded in future studies.
Interestingly, the protecting effect of the enzymemixture was tran-
sient. Between 1 and 2 h after replacement of the enzyme-containing
solution with normal extracellular solution, cells gradually became sus-
ceptible to PlnA. In the same dish, cells regained their sensitivity with
different delays, but after 2 h, virtually all cells were permeabilized
when exposed to PlnA. Live cells continuously synthesize glycoproteins
and proteoglycans that are inserted in the cell membrane. The time
window within which the cells regained sensitivity to PlnA after en-
zyme treatment may thus reﬂect the turnover rate of glycosylated
membrane proteins in the GH4 cell line. The regained PlnA sensitivity
observed after removing the enzyme mixture also indicates that thecells stayed viable during the enzyme treatment and experimental
procedures.
It is well established that the density of negatively charged phos-
pholipids in the outer membrane leaﬂet in cancer cells is increased
relative to that of normal, healthy cells [37–40], and the composition
of membrane-associated macromolecules is also different in normal
and cancerous cells. The expression of proteoglycans and the selec-
tion of carbohydrate moieties of glycoproteins change signiﬁcantly
through neoplastic transformation in malignancies such as lung carci-
noma, ovarian cancer, osteosarcoma, brain tumors, mesothelioma,
colon cancer, breast cancer and pancreatic cancer [41–48]. Such alter-
ations of the glycocalyx, and not only the increased density of nega-
tively charged phospholipids, may explain why some antimicrobial
peptides at certain concentrations preferentially lyse and kill cancer-
ous eukaryotic cells, whereas their normal counterparts are not af-
fected. Initial interaction with membrane- or cell wall-associated
carbohydrates is also essential for the effect of many antimicrobial
peptides on their natural target cells, bacteria [56].
Cationic antimicrobial peptides are promising novel agents for can-
cer treatment [57], and our initial report of selective permeabilization
of cancerous pituitary cells by PlnA was encouraging regarding a possi-
ble clinical potential of the peptide [13]. However, it turned out that
normal rodent neurons, human lymphocytes, and various cancerous
counterparts of these cell types were permeabilized by PlnA at about
the same concentration of the peptide [14]. Normal rat liver cells
(hepatocytes, endothelial cells, and Kupffer cells) and renal epithelial
cells were also permeabilized by PlnA [12]. Thus, the permeabilizing ef-
fect of PlnA on eukaryotic cells is not restricted to cancerous cells. The
literature on the lytic effect of antimicrobial peptides on cancer cells in-
cludes several preliminary, promising reports not corroborated by sub-
sequent publications, which may imply that also other antimicrobial
peptides have turned out to be less selective for cancer cells than indi-
cated by the initial studies. Many attempts at designing peptides with
improved selectivity and potency regarding anti-tumor properties
have been made (reviewed in [11]), but their success has so far been
limited.
However, the notion that high selectivity for tumor cells is crucial for
application of antimicrobial peptides in cancer treatment has recently
been challenged. Local lysis of tumor cells by oncolytic viruses may ac-
tivate a systemic immune response selective for cells from the same
clone as the lysed cells [21,22], and Berge et al. [20] have demonstrated
that local lysis of tumor cells by a lytic peptide derived from lactoferrin
induces a similar, selective immune response. In a series of experiments,
both T cell-deﬁcient and immunocompetentmicewere inoculatedwith
murine lymphoma cells, and, when solid tumors had formed, the lytic
peptide was injected intratumorally. This treatment induced signiﬁcant
inhibition of tumor growth in all the animals. Interestingly, complete
tumor regression and no recurrence was observed in a majority of the
immunocompetent mice, whereas tumor regression was only transient
in the T cell-deﬁcient individuals. Moreover, upon reinoculatingmice in
which tumors had been completely eradicated, renewed tumor growth
was sparse and complete regression of the tumors occurred without
treatment. In contrast, a different syngenetic tumor-forming cell line
readily established lethal tumors when inoculated in mice previously
cured of the lymphoma. These results suggest that lytic peptides may
induce speciﬁc immunity through spillage of antigens from the lysed
cells, thereby rendering the host impervious to reestablishment of tu-
mors by cells from the same clone as the lysed cells.
Because local lysis of cancer cells may activate a speciﬁc, systemic
immune response, and thus initiate an attack on both the injected
tumor and recurrences, strong selectivity for cancer cells is not a pre-
requisite for a lytic peptide to have therapeutic potential. However,
local administration of a non-speciﬁc lytic peptide faces many of the
same challenges as irradiation- and surgical cancer therapy, e.g., se-
vere damage of adjacent healthy tissue. The very steep dose–response
curve of PlnA is particularly interesting in this regard [12–14]. By
258 S.L. Sand et al. / Biochimica et Biophysica Acta 1828 (2013) 249–259intra-tumoral injection of PlnA, it is feasible to reach a local peptide
concentration sufﬁcient to rapidly permeabilize cancer cells, while
the level of PlnA in the bordering regions will be too low to inﬂuence
cell membrane integrity. Therefore, the therapeutic potential of PlnA
and similar peptides may be considerable.
We conclude that electrostatic attraction to not only negatively
charged phospholipids, but also to glycosylated membrane proteins
is probably involved in the PlnA-induced membrane permeabilization
of eukaryotic cells. We envisage that the attraction to negatively
charged membrane proteins is a necessary ﬁrst step, in order for
PlnA to reach a sufﬁciently high concentration close to the lipid bilay-
er for the next step to occur, i.e., interaction with negatively charged
phospholipids and insertion into the outer leaﬂet of the lipid bilayer.
The involvement of speciﬁc carbohydrate residues in this process and
the possible therapeutic potential of PlnA and similar peptides should
be investigated in future studies.Acknowledgements
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